ADVERTISEMENT

Systematix Maintains 'Hold' Rating On Poly Medicure Despite Italy-Based Citieffe Acquisition — Here's Why

There are global players already entrenched in the category and hence Poly Medicure will need to find ways to differentiate to accelerate growth for themselves, adds the brokerage.

<div class="paragraphs"><p>Citieffe operates a 2,100 square meter manufacturing facility in Bologna, Italy, which is currently at 60% capacity utilization.</p><p>(Photo: company website)</p></div>
Citieffe operates a 2,100 square meter manufacturing facility in Bologna, Italy, which is currently at 60% capacity utilization.

(Photo: company website)

Poly Medicure has announced the acquisition of the Citieffe Group, its second acquisition in September. The acquisition is part of Poly Medicure inorganic growth strategy, which focuses on acquiring high-technology companies that provide access to key markets like Europe and the US. The acquisition of Citieffe provides a platform for PLM to expand into the orthopedics segment, specifically focusing on the fastgrowing trauma and extre...
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit